Candriam SCA’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.8M | Sell |
844,249
-13,913
| -2% | -$195K | 0.07% | 224 |
|
|
2025
Q1 | $11.7M | Buy |
858,162
+25,185
| +3% | +$342K | 0.07% | 223 |
|
|
2024
Q4 | $17M | Sell |
832,977
-109,181
| -12% | -$2.23M | 0.1% | 190 |
|
|
2024
Q3 | $27.4M | Buy |
942,158
+215,659
| +30% | +$6.28M | 0.16% | 137 |
|
|
2024
Q2 | $16.9M | Buy |
726,499
+278,621
| +62% | +$6.47M | 0.1% | 197 |
|
|
2024
Q1 | $9.19M | Buy |
447,878
+90,000
| +25% | +$1.85M | 0.06% | 265 |
|
|
2023
Q4 | $7.68M | Hold |
357,878
| – | – | 0.05% | 290 |
|
|
2023
Q3 | $7.38M | Hold |
357,878
| – | – | 0.05% | 263 |
|
|
2023
Q2 | $10.6M | Hold |
357,878
| – | – | 0.08% | 240 |
|
|
2023
Q1 | $7.59M | Hold |
357,878
| – | – | 0.05% | 298 |
|
|
2022
Q4 | $9.95M | Hold |
357,878
| – | – | 0.07% | 279 |
|
|
2022
Q3 | $11M | Buy |
357,878
+34,996
| +11% | +$1.07M | 0.08% | 246 |
|
|
2022
Q2 | $9.5M | Buy |
322,882
+181,375
| +128% | +$5.34M | 0.08% | 231 |
|
|
2022
Q1 | $4.55M | Hold |
141,507
| – | – | 0.03% | 366 |
|
|
2021
Q4 | $6.31M | Buy |
141,507
+77,726
| +122% | +$3.47M | 0.04% | 315 |
|
|
2021
Q3 | $3.22M | Hold |
63,781
| – | – | 0.02% | 481 |
|
|
2021
Q2 | $5M | Buy |
+63,781
| New | +$5M | 0.03% | 405 |
|